2-233637119-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_019075.4(UGT1A10):c.597T>C(p.Asp199Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00211 in 1,613,958 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.011 ( 45 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 35 hom. )
Consequence
UGT1A10
NM_019075.4 synonymous
NM_019075.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.521
Genes affected
UGT1A10 (HGNC:12531): (UDP glucuronosyltransferase family 1 member A10) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity on mycophenolic acid, coumarins, and quinolines. [provided by RefSeq, Jul 2008]
UGT1A8 (HGNC:12540): (UDP glucuronosyltransferase family 1 member A8) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including coumarins, phenols, anthraquinones, flavones, and some opioids. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-233637119-T-C is Benign according to our data. Variant chr2-233637119-T-C is described in ClinVar as [Benign]. Clinvar id is 775833.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.521 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0114 (1733/152298) while in subpopulation AFR AF = 0.0394 (1637/41548). AF 95% confidence interval is 0.0378. There are 45 homozygotes in GnomAd4. There are 818 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 45 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT1A10 | NM_019075.4 | c.597T>C | p.Asp199Asp | synonymous_variant | Exon 1 of 5 | ENST00000344644.10 | NP_061948.1 | |
UGT1A8 | NM_019076.5 | c.855+18557T>C | intron_variant | Intron 1 of 4 | ENST00000373450.5 | NP_061949.3 | ||
UGT1A | n.233637119T>C | intragenic_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT1A10 | ENST00000344644.10 | c.597T>C | p.Asp199Asp | synonymous_variant | Exon 1 of 5 | 1 | NM_019075.4 | ENSP00000343838.5 | ||
UGT1A10 | ENST00000373445.1 | c.597T>C | p.Asp199Asp | synonymous_variant | Exon 1 of 5 | 1 | ENSP00000362544.1 | |||
UGT1A8 | ENST00000373450.5 | c.855+18557T>C | intron_variant | Intron 1 of 4 | 1 | NM_019076.5 | ENSP00000362549.4 |
Frequencies
GnomAD3 genomes AF: 0.0113 AC: 1726AN: 152180Hom.: 45 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1726
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00292 AC: 734AN: 251098 AF XY: 0.00198 show subpopulations
GnomAD2 exomes
AF:
AC:
734
AN:
251098
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00114 AC: 1666AN: 1461660Hom.: 35 Cov.: 32 AF XY: 0.000923 AC XY: 671AN XY: 727140 show subpopulations
GnomAD4 exome
AF:
AC:
1666
AN:
1461660
Hom.:
Cov.:
32
AF XY:
AC XY:
671
AN XY:
727140
show subpopulations
African (AFR)
AF:
AC:
1436
AN:
33472
American (AMR)
AF:
AC:
74
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
7
AN:
86250
European-Finnish (FIN)
AF:
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
AC:
6
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
29
AN:
1111836
Other (OTH)
AF:
AC:
114
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
126
252
379
505
631
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0114 AC: 1733AN: 152298Hom.: 45 Cov.: 32 AF XY: 0.0110 AC XY: 818AN XY: 74462 show subpopulations
GnomAD4 genome
AF:
AC:
1733
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
818
AN XY:
74462
show subpopulations
African (AFR)
AF:
AC:
1637
AN:
41548
American (AMR)
AF:
AC:
39
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68026
Other (OTH)
AF:
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
81
162
242
323
404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 19, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.